Examining the DNA for Success | Dr Gordon Sanghera, CEO Oxford Nanopore Technologies
LSEG’s Marcus Stuttard speaks to Dr Gordon Sanghera, CEO and Co-Founder of Oxford Nanopore Technologies, about the UK-based biotech company’s route to market and the benefits that has bought them, from credibility amongst global investors to attracting top talent.
As the discussion uncovers, what really sets the business apart is their extraordinary clinical research and scalable technology solutions. Dr Sanghera also explains how Oxford Nanopore has created a revolutionary DNA & RNA sequencing device which will bring huge benefits to humanity in early disease and cancer diagnosis. The very definition of an inspiring company.
#BeInspired #CEOInsights #londonstockexchange
Check out more episodes of the Be Inspired CEO series: https://bit.ly/3vfpLlc
Subscribe to LSEG’s YouTube channel to get new episodes of Be Inspired, Net Zero Conversations, The Big Conversation and more. New financial insights are uploaded every weekday: https://www.youtube.com/lsegplc
If you have any questions about this episode, financial markets or the economy, please leave us a comment or email fmt@lseg.com.
London Stock Exchange podcast
Spotify: https://spoti.fi/3Qb7UnP
Apple Podcasts: https://apple.co/3zFz5l7
Google Podcasts: https://bit.ly/3PP8GXC
Web: https://bit.ly/3SftpWo
RSS: https://bit.ly/3oHi9V2
Responses